Introduction
Toxoplasma gondii, the etiological agent of toxoplasmosis, is a parasite that establishes a safe niche in the cytoplasm of all host cells -the parasitophorous vacuole (PV). This environment surrounds the parasite and has a close association with the host cell mitochondrial membrane and endoplasmic reticulum (1, 2) , but is free of host cell protein (2) . Thus, the PV is not acidified and is resistant to fusion with host endocytic and lysosomal compartments (3, 4) . Once inside the cell, T. gondii begins to grow and divide by endodyogeny (5, 6) and while developing it captures nutrients such as phospholipids (7) , cholesterol, glucose, and purine nucleosides from the host cell (8, 9) .
The T. gondii-host cell interaction is a good system to study the action of drugs and the behavior of infected host cells and cell cycle inhibition has been shown to be a useful target for drug development (10) . We initially used an anti-proliferative drug hydroxyurea (HU) against intracellular parasites such as T. gondii, Leishmania amazonensis and Trypanosoma cruzi. This drug arrested the replication of these microorganisms, resulting in parasite elimination and reduced infection in vitro (11, 12) .
HU is a urea derivative, which has the basic structure HONH-CO-NH 2 , and thiosemicarbazone has the structure R 2 C=N-NH-CS-NHR. HU and thiosemicarbazones are known to inhibit the cell cycle in the G1/S phase, mainly inactivating ribonucleotide reductase, an enzyme that mediates the conversion of ribonucleotides to deoxyribonucleotides (13) . Recently, we demonstrated that TSC and analog compounds, 4-thiazolidinones (4-TZD), decreased in vitro infection and eliminated intracellular T. gondii (14) . This study used TSC substituted at the arylhydrazone moiety with a nitro substituent at the ortho, meta and para positions, and 4-TZD substituted at the N-3 position with a phenyl, methyl and hydrogen substituent, and with the same groups at the arylhydrazone moiety. Compounds bearing a heterocyclic 4-TZD have high biological activity including antimicrobial (15) , antiviral (16) , anti-inflammatory (17) , hypnotic (18) , and antiprotozoal activity (19, 20) . Both TSC and TZD compounds reduced infection, but the 4-TZD compounds were more efficient (14) .
The radical change in the molecule's structure should improve efficacy of the molecules, increasing their antiparasitic or anti-proliferative effect. Thus, the aim of the present study was to evaluate the effects of new TSC and TZD compounds that have one arylhydrazone moiety with a hydrogen, chlorine and nitro group (Figure 1 ) against intracellular T. gondii. It is important to point out that the standard therapies for toxoplasmosis -the combination of pyrimethamine and sulfadiazine, clindamycin, azithromycin, or atavaquone (21,22) -do not eliminate the intracellular parasite and are often associated with severe side effects (23) . This has increased the need to develop new drugs. Furthermore, we report the morphological features of parasite destruction in the presence of the drugs in order to identify the cellular mechanism associated with the microbicidal effects of the compounds tested.
Material and Methods

Host cells
Vero cells (kidney fibroblasts of the African monkey) were grown in plastic Falcon flasks (25 cm 2 ) containing medium 199 (Sigma, USA) with 5% fetal calf serum (FCS; Gibco, USA), and were trypsinized when the cell density approached a semi-confluent monolayer. One day before use in the experiments, approximately 3 x 10 4 cells were placed on Linbro 24-well tissue plates containing a sterile round coverslip, or were placed in 25-cm 2 flasks (3-5 x 10 5 / flasks), and maintained at 37°C overnight in a 5% CO 2 , 95% air atmosphere.
Parasites
Tachyzoites from the virulent RH strain of T. gondii were maintained by intraperitoneal passages in Swiss mice and were collected in phosphate-buffered saline (PBS), pH 7.2, 48 h after infection. The ascitic fluid obtained from infected mice, which contained the parasites, was collected and centrifuged at 300 g for 10 min. The pellet obtained was washed with PBS, pH 7.2, and suspended to a density of 10 7 parasites/mL in medium 199 without FCS. The parasites were used about 30 min after removal from infected animals, and viability was evaluated using a dye-exclusion test with 0.2% Trypan blue (w/v). All procedures for the use of animals followed the Ethical Guidelines for Animal Experimentation of the Universidade Estadual do Norte Fluminense.
Host cell-parasite interaction
Parasites suspended in medium 199 were incubated for 2 h in the presence of Vero cells using a 5:1 parasite-host cell ratio. After incubation, the cells were washed twice with medium 199 to remove extracellular parasites, and incubated for 24 h at 37°C. The compounds described below were then added to the cultures.
Chemistry
The synthesis of TSC (1-3) and 4-TZD (4-6) derivatives ( Figure 1 ) followed the method described by Tenório et al. (14) . The chemical names of the compounds are the following: compound 1 (benzaldehyde thiosemicarbazone); compound 2 (para-chloro-benzaldehyde thiosemicarbazone); compound 3 (para-nitro-benzaldehyde thiosemicarbazone);
. Briefly, the TSC 1, 2, and 3 were obtained by reaction between the thiosemicarbazide and the respective benzaldehydes substituted in acid medium under reflux, at satisfactory yields (56-96%). These compounds were then cyclized with excess maleic anhydride in dry toluene and N,N-dimethylformamide to yield the respective 4-TZD derivatives 4, 5, and 6 (52-96%). All compounds are stable both in the solid and solution state. Spectroscopic data for these compounds were consistent with their structure. HU was obtained from Sigma and sulfadiazine from Merck (USA).
Incubation with the compounds
After incubation of the cells with the parasites for 24 h, the cells were incubated with the compounds described above. TSC and TZD and derivatives were used at a final concentration of 1 mM for biological assays. This concentration was selected according to the concentration screen (0.1 to 20 mM), and following preliminary experiments and previous studies carried out by Tenório et al. (14) . HU and sulfadiazine were used as the reference drugs, at 4 and 1 mM, respectively, according our previous data (11, 14) . All drugs were dissolved in DMSO and added to medium 199. DMSO was used at a final concentration of 1% (v/v), which was not toxic for Vero cells or intracellular T. gondii. Infected cells were incubated in the presence of HU and compounds 1-6 for 12 or 24 h. In order to determine the reversible effect of the compounds on the parasites, the medium containing the drug was removed and the cultures were incubated for 24 h with fresh medium 199 supplemented with 5% FCS, at 37°C in 5% CO 2 . Trypan blue (0.2% w/v) was used to assay the viability of treated and untreated host cells.
Morphological analyses and quantification
For morphological analyses, infected and treated cultures were rinsed with PBS, pH 7.2, at 37°C. Cells were then fixed with Bouin's solution for 15 min and stained with Giemsa (10% v/v), for 2 h at room temperature. All preparations were examined using a Zeiss Axioplan photomicroscope equipped with a 63X objective. The images were obtained with the Analysis System software (Germany).
At least 300 cells in the same monolayer were scored at 400X magnification for each drug and each time tested. The following parameters were analyzed in treated and untreated cultures: a) normal intracellular parasites, which have a crescent shape; b) infected cells containing parasites with normal morphology; c) infected cells containing parasites with altered morphology; d) parasitophorous vacuoles containing altered parasites. Finally, the LD50 values of all compounds for host cells and intracellular tachyzoites were obtained after 24 h of exposure at the concentration of 0.1-20 mM.
Statistical analysis was performed by twoway ANOVA (Graph Pad Prism). P values of <0.05 were considered to be significant. The data reported here are representative of three experiments performed in quadruplicate.
Ultrastructural analyses
For ultrastructural analyses, Vero cells were placed in culture flasks (75 cm 2 ) and infected with parasites as described before. After incubation with the drugs, the cultures were washed with PBS at 37°C and fixed at room temperature in a solution containing 1% glutaraldehyde, 4% paraformaldehyde, 5 mM CaCl 2 , and 5% sucrose in 0.1 M-cacodylate buffer, pH 7.2. Cells were then post-fixed for 1 h in a solution containing 2% OsO 4 , 0.8% potassium ferrocyanide, and 5 mM CaCl 2 in 0.1 M-cacodylate buffer, pH 7.2. Samples were rinsed with 0.1 M cacodylate buffer, pH 7.2, dehydrated in acetone and embedded in PolyBed (Polyscience Inc., USA). Thin sections were stained with uranyl acetate and lead citrate and observed with a Zeiss 900 Transmission Electron Microscope at 80 kV acceleration.
Vacuolar acidification
To examine vacuolar acidification, treated and untreated infected cultures were incubated with a solution of acridine orange (AO) dye (Sigma), at a final concentration of 5 μg/mL for 20 min (24) . Live samples were then washed with culture medium and examined under a Zeiss Confocal Laser Scan Microscope using a 488-nm or 543-nm argon laser.
Results
Vero cells infected with T. gondii for 24 h presented an established infection with a high number of intravacuolar tachyzoites. These infected cultures were then incubated in the presence of TSC and 4-TDZ for 12 and 24 h. Quantitative and morphological analyses were performed to observe the anti-T. gondii action of the drugs.
According to Tables 1 and 2 , the action of all compounds 158 ± 9 165 ± 9 144 ± 5 206 ± 4 169 ± 7 87 ± 6 4 146 ± 2 160 ± 9 147 ± 8 224 ± 5 290 ± 6 65 ± 9 5 163 ± 8 180 ± 9 144 ± 16 270 ± 7 158 ± 2 172 ± 4 6 199 ± 5 168 ± 7 155 ± 7 210 ± 6 180 ± 1 182 ± 6 Hydroxyurea 205 ± 9 168 ± 5 180 ± 9 113 ± 6 167 ± 1 180 ± 7 Sulfadiazine 98 ± 7 130 ± 2 136 ± 2 79 ± 2 54 ± 1 14 ± 2 Tables 1 and 2 , a 1-mM concentration of the drugs was used in all experiments described below.
After treatment with the TSC and 4-TZD derivatives, microscopy revealed that intravacuolar parasites became altered during treatment.
In the untreated cultures, infected cells contained parasites with normal morphology in a crescent shape, multiplying inside the PV. The percentage of infected cells and the mean number of parasites are shown in Figure 2 . In the presence of TSC (compounds 1-3) and 4-TZD (compounds 4-6; Figure 1 ), the percentage of infected cells containing normal parasites decreased after treatment for 12 h ( Figure  2A ) and even more so after 24 h ( Figure 2B ). Infection was also reduced by incubation with HU to a level similar to that observed for the new compounds (Figure 2 ). HU used for comparison (11, 12 ) was 4 mM and other compounds were 1 mM. The reduction in infection was closely associated with the disorganization and elimination of normal parasites after 12 h of treatment, at which point morphologically normal tachyzoites were greatly decreased in number ( Figure 2C ). After 24 h they were completely absent in the presence of some of the compounds ( Figure 2D) .
Tachyzoites in the untreated culture formed a rosette arrangement and had a crescent shape ( Figure 3A) . During treatment with all compounds, these intravacuolar parasites showed changes such as a rounded shape and the disruption of the rosette arrangement ( Figure 3B ). PVs containing altered or disorganized parasites were quantified in order to demonstrate the destruction of tachyzoites (Figure 4 ). Parasites were unchanged in untreated cultures. Thus, the number of vacuoles containing altered parasites was determined only in the treated cultures. The number of infected cells (Figure 2A,B) with vacuoles containing disorganized and/or disrupted parasites progressively decreased between 12 and 24 h, leading to the elimination of tachyzoites from the host cell. Differences observed among the compounds in terms of the decrease in vacuoles containing altered parasites (Figure 4 ) suggest that elimination of these vacuoles is closely associated with the efficiency of the anti-parasite compounds. Overall, all compounds decreased the infection in a similar way, except compounds 3 and 4, which induced a significant decrease of the number of these PVs, suggesting that these disrupted parasites had been eliminated from the host cell ( Figure  4 ). In addition, none of the compounds used here caused drastic cytotoxic effects to the host cell, as demonstrated by the Trypan blue test (data not shown).
T. gondii has specialized organelles such as micronemes, rhoptries and dense granules that are distributed in the apical region, and an inner membrane complex and the outer plasma membrane ( Figure 3C ). These features changed in the presence of TSC and TZD, as demonstrated in Figure 3D -F, being similar for all compounds. The main alteration was a progressive vesiculation in the cytoplasm of the parasite ( Figure 3D ,E) after 12 h of treatment. This figure shows daughter tachyzoites that did not complete multiplication ( Figure 3D , arrowhead in inset). However, secretory organelles, such as dense granules and rhoptries, were present. After incubation for 24 h, increasing vesiculation was observed inside the tachyzoites ( Figure 3E ). Some vacuoles within the parasite's cytoplasm had dense and amorphous materials, and secretory organelles were not visible ( Figure 3E ). The vesiculation process was a consequence of the arrest of the cell cycle in the parasites and could involve secretory vesicle disorganization, features that are vital for the survival of intracellular parasites. However, different degrees of ultrastructural disorganization were seen inside the same PV, suggesting an asynchronous effect on tachyzoite development ( Figure 3F) . In this micrograph, we also observed parasite multilamellar structures inside their cytoplasm, such as the myelin-like figure (Figure 3F , inset). This same parasite had mitochondria, but secretory organelles were not observed. The vesiculation observed in the parasites was not seen in the host cells ( Figure 3C-F) , in which mitochondria and endoplasmic reticulum elements were seen around the PV but were not more highly associated with the PV membrane ( Figure 3D-F) , suggesting interruption of the close association between PV-containing parasites and host cell organelles.
To determine whether incubation with the compounds had a reversible anti-Toxoplasma effect, a reversibility assay was performed. Infected monolayers were incubated with compounds 1 and 4 for 12 and 24 h, the medium was then removed and the cultures were incubated for another 24 h with fresh medium. After 12 h of treatment parasites that had a normal morphology resumed their multiplication once the drugs were removed ( Figure 5A,B) . The number of parasites increased significantly after the reversible assay with cultures treated for 12 h ( Figure 5B ). After 24 h of treatment, an increase in intracellular parasites occurred with compound 1 but infection did not increase ( Figure 5B ). The number of PVs containing altered parasites was similar in all reversibility assays, except for compound 1 at 24 h, which showed a decrease related to time of culture treatment ( Figure 5C ). These observations could be the result of asynchronous infection, in which parasites are present at several steps of the cell cycle. However, since the parasites were altered during treatment, this effect was not reversible and the parasites were unable to multiply.
Although the normal parasites resumed their cell cycle, the rosette structure was rarely observed (Figure 6A,B) . Abnormal intravacuolar tachyzoites remained in the culture during treatment for 12 h and showed disorganized morphological aspects, as illustrated in Figure 6A . However, PV-containing parasites were eliminated, or only a few remained in the host cell cytoplasm ( Figure 6B ). The different stages of the destruction process were evident in a single vacuole, as shown in Figure 6 . Tachyzoites showed progressive ultrastructural disorganization after 12 h of treatment. These data support the view that compounds of this class arrest the parasite's cycle and have their antiparasite effects only in determinate phases of parasite division and development.
We showed the possible processes responsible for intravacuolar elimination of parasites in the presence of the compounds. In untreated cultures, the PV did not stain with AO, confirming the non-acidic nature of this compartment ( Figure 7A,B) . By using AO in cultures treated with compound 2, we observed positive vesicles in the host cells and in the PV, an indication that acidification had occurred in this environment (Figure 7C,D) . In addition, the vesicles in the host cell cytoplasm were stained more strongly than the PV. The AO-positive vacuoles contained disorganized parasites ( Figure 7D ), whereas the untreated culture con- tained parasites forming rosette structures. The acidification is probably caused by lysosome fusion, as demonstrated after HU treatment (25) .
Discussion
Standard treatment of toxoplasmosis is accompanied by severe side effects; thus, alternative therapeutic compounds are needed. The present study was performed to evaluate the efficacy of new thiosemicarbazone against T. gondii. The TSC scaffold has advantages in the synthesis of new compounds, such as low molecular weight, good hydrogen bond donating and accepting capabilities, and easy, economical synthesis routes.
Recent research has demonstrated the efficacy of TSC compounds associated with metal, such as platinum, against Trypanosoma cruz, with potent activity against cruzain (26) . Others showed that metronidazole-thiosemicarbazone compounds were highly effective for Entamoeba histolytica (27) and Plasmodium spp (28) . Despite the wide pharmacological range of this class of compounds, drugs used here preferentially affected intravacuolar tachyzoites of T. gondii.
The compounds used here have H, Cl or NO 2 groups on the arylhydrazone moiety. This chemical structure showed anti-parasitic effects similar to those described by Tenório et al. (14) . The best compound was acid [2-(benzylidenehydrazone)-4-oxo-1,3-thiazolidin-5-yl]acetic, that had an The mechanism of action of TSC and TZD compounds is mainly associated with ribonucleotide reductase inhibition, as is that of HU (29) , but it may also involve inhibition of other metallic proteins involved in metabolic processes.
The ability of TSC to arrest the cell cycle has been used in a variety of situations, such as antitumoral, antiviral, and anti-protozoa treatments (29, 30) . Another TSC, Triapine ® , has also shown significant activity on tumor cells (31) and was tested in a phase I clinical trial. Melo and Beiral (12) demonstrated that HU was efficient in arresting the multiplication of Leishmania amazonensis and Trypanosoma cruzi. Due to their intrinsic metal (e.g., iron) chelating properties, the mechanism of action of TSC is also believed to result from the generation of reactive oxygen radical (28) . In relation to T. gondii destruction, the present study described for the first time the main morphological features associated with TSC action.
During incubation with these drugs progressive tachyzoite disorganization and destruction were observed. This was demonstrated by the number of PV containing progressively disorganized parasites before the elimination process, and normal parasite recovery was observed in the absence of the drug, strongly suggesting that these compounds must be acting on a specific stage of the parasite's cell cycle, as also observed for HU. We also observed intense vesiculation in the parasites during incubation with the drugs and the development of myelin figures, which are associated with cell death in the parasite. Myelin figures are polar lipid-rich structures containing cholesterol, phosphatidylcholine, and sphingomyelin (32) , which are capable of activating numerous metabolic pathways, especially those involved in apoptosis. In addition, the entire vesiculation process occurred in the secretory system of the parasite, which has a vital biological activity for tachyzoite survival and development.
Some studies have already explored the morphological features associated with Toxoplasma death. Ling et al. (33) described a series of intracellular mechanisms used by primed macrophage to destroy T. gondii. They showed that this mechanism occurs frequently at early stages of infection, and is characterized by changes of the parasitophorous vacuole membrane and parasite disorganization, which lead to autophagic processes and lysosomal degradation. A recent study by our group (25) also showed that the disorganization and destruction of intravacuolar Toxoplasma in the presence of HU, using non-macrophage cells, involved fusion between the lysosomes of host cells and the vacuole containing the parasites. These cellular aspects demonstrate that the PV becomes permissive to lysosome fusion when the parasite is dead after the PV has formed and developed. On the other hand, death due to pyrimethamine does not lead to PV fusion with lysosomes (3). Similar to HU, the parasite death resulting from incubation with TSC and TZD led to vacuolar acidification, preventing tachyzoites from developing in the PV. This event is associated with elimination of the parasite by the digestive pathway of the host cell -a major mechanism of cell defense against microorganism invasion.
During treatment, the host cell organelles associated with PV-containing tachyzoites, mainly mitochondria and endoplasmic reticulum, were abolished. These results conflict with those obtained by Sinai and Joiner (34) , which demonstrated that the mitochondria remain joined to the PV after treatment of intracellular T. gondii with pyrimethamine, an anti-metabolic drug. The mitochondrial association with PV was demonstrated to involve the rhoptry protein ROP2, which exposes its amino-terminus containing an amphipathic helix reminiscent of mitochondrial import sequences (35) . It would be interesting to investigate whether this molecular association is lost during treatment with antimetabolic or antiproliferative drugs.
Overall, we consider the results obtained so far to be promising since they provide new and relevant data about thiosemicarbazones and their specific action on the Apicomplexa parasite. The efficiency of TSC compounds in interrupting cell multiplication supports the potential extensive application of TSC and TZN to antiparasite therapy.
